These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 12384682)

  • 1. Immunology: catch us if you can.
    Yokoyama WM
    Nature; 2002 Oct; 419(6908):679-80. PubMed ID: 12384682
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation.
    Groh V; Wu J; Yee C; Spies T
    Nature; 2002 Oct; 419(6908):734-8. PubMed ID: 12384702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.
    Song H; Kim J; Cosman D; Choi I
    Cell Immunol; 2006 Jan; 239(1):22-30. PubMed ID: 16630603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Now you see it, now you don't!
    Yokoyama WM
    Nat Immunol; 2000 Aug; 1(2):95-7. PubMed ID: 11248795
    [No Abstract]   [Full Text] [Related]  

  • 5. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.
    Armeanu S; Bitzer M; Lauer UM; Venturelli S; Pathil A; Krusch M; Kaiser S; Jobst J; Smirnow I; Wagner A; Steinle A; Salih HR
    Cancer Res; 2005 Jul; 65(14):6321-9. PubMed ID: 16024634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.
    Wrobel P; Shojaei H; Schittek B; Gieseler F; Wollenberg B; Kalthoff H; Kabelitz D; Wesch D
    Scand J Immunol; 2007; 66(2-3):320-8. PubMed ID: 17635809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic release of soluble UL16-binding protein 2 from tumor cells.
    Waldhauer I; Steinle A
    Cancer Res; 2006 Mar; 66(5):2520-6. PubMed ID: 16510567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands.
    Kaiser BK; Yim D; Chow IT; Gonzalez S; Dai Z; Mann HH; Strong RK; Groh V; Spies T
    Nature; 2007 May; 447(7143):482-6. PubMed ID: 17495932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.
    Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A
    Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral modulation of NK cell immunity.
    Lodoen MB; Lanier LL
    Nat Rev Microbiol; 2005 Jan; 3(1):59-69. PubMed ID: 15608700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular ligands of activating NK receptors.
    Bottino C; Castriconi R; Moretta L; Moretta A
    Trends Immunol; 2005 Apr; 26(4):221-6. PubMed ID: 15797513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules.
    Johansson S; Johansson M; Rosmaraki E; Vahlne G; Mehr R; Salmon-Divon M; Lemonnier F; Kärre K; Höglund P
    J Exp Med; 2005 Apr; 201(7):1145-55. PubMed ID: 15809355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A trigger of natural (and other) killers.
    Hagmann M
    Science; 1999 Jul; 285(5428):645, 647. PubMed ID: 10454908
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein.
    Welte SA; Sinzger C; Lutz SZ; Singh-Jasuja H; Sampaio KL; Eknigk U; Rammensee HG; Steinle A
    Eur J Immunol; 2003 Jan; 33(1):194-203. PubMed ID: 12594848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunology. NK cells lose their inhibition.
    Parham P
    Science; 2004 Aug; 305(5685):786-7. PubMed ID: 15297654
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of killer immunoglobulin-like receptors and their HLA Class I ligands with progression of chronic hepatitis C virus infection.
    López-Vázquez A; Rodrigo L; López-Larrea C
    Tissue Antigens; 2007 Apr; 69 Suppl 1():241-2. PubMed ID: 17445210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.
    Gilfillan S; Ho EL; Cella M; Yokoyama WM; Colonna M
    Nat Immunol; 2002 Dec; 3(12):1150-5. PubMed ID: 12426564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
    Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cytolytic T lymphocytes expressing HLA class-I-specific inhibitory receptors.
    Mingari MC; Pietra G; Moretta L
    Curr Opin Immunol; 2005 Jun; 17(3):312-9. PubMed ID: 15886123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How NKG2D ligands trigger autoimmunity?
    Caillat-Zucman S
    Hum Immunol; 2006 Mar; 67(3):204-7. PubMed ID: 16698443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.